Bluejay Diagnostics (BJDX) Prepaid Assets (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Prepaid Assets of $145670.0 for Q1 2026, down 68.06% on a YoY basis from $456079.0 in Q1 2025, and down 47.21% sequentially from $275957.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Prepaid Assets (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 7 years of Prepaid Assets data on file, last reported at $145670.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 68.06% year-over-year to $145670.0; the trailing twelve-month figure through Mar 2026 stood at $145670.0 (down 68.06% YoY), and the FY2025 full-year result was $275957.0, down 43.59% from the prior year.
- Prepaid Assets declined to $145670.0 in Q1 2026, from $275957.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.5 million in Q3 2023 to a low of $69550.0 in Q3 2025.
- A 5-year average of $509521.2 and a median of $360458.0 in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 258.78% in 2024 and plunged 88.25% in 2025, its largest moves.
- Tracing BJDX's Prepaid Assets over 5 years: stood at $240283.0 in 2022, then plunged by 43.26% to $136342.0 in 2023, then jumped by 258.78% to $489174.0 in 2024, then sank by 43.59% to $275957.0 in 2025, then tumbled by 47.21% to $145670.0 in 2026.
- Business Quant data shows BJDX's Prepaid Assets at $145670.0 in Q1 2026, $275957.0 in Q4 2025, and $69550.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145,670.00 |
| Dec 31, 2025 | 275,957.00 |
| Sep 30, 2025 | 69,550.00 |
| Jun 30, 2025 | 305,478.00 |
| Mar 31, 2025 | 456,079.00 |
| Dec 31, 2024 | 489,174.00 |
| Sep 30, 2024 | 591,935.00 |
| Jun 30, 2024 | 186,294.00 |
| Mar 31, 2024 | 788,578.00 |
| Dec 31, 2023 | 136,342.00 |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 178,469.00 |
| Mar 31, 2023 | 360,458.00 |
| Dec 31, 2022 | 240,283.00 |
| Sep 30, 2022 | 646,894.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Sep 30, 2021 | 451,407.00 |
| Dec 31, 2020 | 61,071.00 |